Related Experiment Video

Updated: Jun 4, 2026

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Hyperglycaemia in preterm neonates: what to know, what to do

Marcelo H Decaro1, Nestor E Vain

  • 1FUNDASAMIN, Buenos Aires, Argentina.

Early Human Development
|February 1, 2011
PubMed

Insights

Neonatal hyperglycemia, common in very low birth weight (VLBW) infants, has unclear definitions and causes. This condition is linked to higher mortality and morbidity, with limited treatment guidelines for these vulnerable infants.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Critical Care Medicine

Background:

  • Neonatal hyperglycemia is a frequent complication in very low birth weight (VLBW) infants within the first week of life.
  • Common causes include excessive glucose administration, physiological stress (sepsis, necrotizing enterocolitis, surgery), and medications like vasoactive drugs and methylxanthines.
  • The precise definition and clinical implications of neonatal hyperglycemia remain incompletely understood.

Purpose of the Study:

  • To review the current understanding of neonatal hyperglycemia in VLBW infants.
  • To highlight the associated morbidities and mortality.
  • To identify gaps in knowledge regarding optimal definitions, treatment strategies, and insulin pharmacokinetics.

Main Methods:

  • Literature review of existing studies on neonatal hyperglycemia.
  • Analysis of common etiological factors and clinical outcomes.
  • Assessment of the current evidence base for treatment interventions.

Main Results:

  • Neonatal hyperglycemia is associated with increased mortality and significant morbidities in VLBW infants.
  • Insufficient randomized clinical trials exist to guide treatment decisions.
  • Data on insulin pharmacokinetics in this population are limited, hindering targeted therapy.

Conclusions:

  • Neonatal hyperglycemia is a critical concern in VLBW infants, linked to adverse outcomes.
  • Further research, particularly well-designed randomized clinical trials, is essential to establish clear definitions and effective treatment protocols.
  • Understanding insulin pharmacokinetics is crucial for managing hyperglycemia in this vulnerable group.

More Related Videos

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...